Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Clinical trial NCT01566747 · COMPLETED

Trial details

NCT number: NCT01566747
Sponsor: Cancer Trials Ireland
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2011-03-01
Primary completion: 2020-04-07
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.